Neuroendocrine and Cardiovascular Risk Factors in Adults with Pituitary Growth Hormone Deficiency (Literature Review)

S.I. Ismailov, A.B. Grossman, M.Yu. Shakirova, Yu.M. Urmanova

Abstract


In this article authors discussed the results of literature review, which has been dedicated to study of different complications of growth hormone deficiency in adults, referring to the literature of the last 10–15 years. Based on this analysis, the authors concluded that in adults with growth hormone deficiency there is an adverse profile of cardiovascular risk. Patients with growth hormone deficiency have an adverse lipid profile, elevated body mass index, increased waist circumference and a high risk of hypertension. These disorders are likely to explain the increased cardiovascular mortality observed in patients with hypopituitarism, regardless of the etiology of growth hormone deficiency in adults.


Keywords


growth hormone deficiency in adults; hypopituitarism; complications

References


Abs R., Bengtsson B.-Е., Hernberg-Stеhl E. GH replacement in 1034 growth hormone deficient adults: demographic and clinical characteristics, dosing and safety // Clinical Endocrinology. — 1999. — Vol. 50. — P. 703-713.

Abs R., Feldt-Rasmussen U., Mattsson A.F. Determinants of cardiovascular risk in 2589 hypopituitary growth hormone-deficient adults // European Journal of Endocrinology. — 2006. — Vol. 155. — P. 79-90

Abs R., Mattsson A.F., Bengtsson B.-Е. Isolated growth hormone (GH) deficiency in adult patients: baseline clinical characteris-tics and responses to GH replacement in comparison with hypopituitary patients. A sub-analysis of the KIMS database // Growth Hormone and IGF Research. — 2005. — Vol. 15. — P. 349-359.

Abdu T.A., Neary R., Elhadd T.A. Coronary risk in growth hormone deficient hypopituitary adults: increased predicted risk is due largely to lipid profile abnormalities // Clinical Endocrinology. — 2001. — Vol. 55. — P. 209-216.

Abrams P., Abs R. The lipid profile in adult hypopituitary patients with growth hormone deficiency // Growth Hormone Deficiency. 10 Years of KIMS / Eds. R. Abs and U. Feldt-Rasmussen. — Oxford, UK: Oxford PharmaGenesisTM Ltd, 2004.

Bates A.S., Van’t Hoff W., Jones P.J. The effect of hypopituitarism on life expectancy // Journal of Clinical Endocrinology and Metabolism. — 1996. — Vol. 81. — P. 1169-1172.

Bates A.S., Bullivant B., Sheppard M.C. Life expectancy following surgery for pituitary tumours // Clinical Endocrinology. — 1999. — Vol. 50. — P. 315-319.

Bengtsson B.-Е. Untreated growth hormone deficiency explains premature mortality in patients with hypopituitarism // Growth Hormone and IGF Research. — 1998. — Vol. 8. — P. 480-485.

Bengtsson B.-Е., Abs R., Bennmarker H. The effects of treatment and the individual responsiveness to growth hormone (GH) replacement therapy in 665 GH-deficient adults. KIMS Study Group and the KIMS International Board // Journal of Clinical Endocrinology and Metabolism. — 1999. — 84. — 3929-3935.

Beshyah S.A., Johnston D. Cardiovascular disease and risk factors in adults with hypopituitarism // Clinical Endocrinology. — 1999. — Vol. 50. — P. 1-15.

Beshyah S.A., Henderson A., Niththyanathan R. Metabolic abnormalities in growth hormone deficient adults: carbohydrate tolerance and lipid metabolism // Endocrinology and Metabolism. — 1994. — Vol. 1. — P. 173-180.

Beshyah S.A., Henderson A., Niththyananthan R. The effect of short and long-term growth hormone replacement therapy in hypopituitary adults on lipid metabolism and carbohydrate tolerance // Journal of Clinical Endocrinology and Metabolism. — 1995. — Vol. 80. — P. 356-363.

Beshyah S.A., Freemantle C., Thomas E. Abnormal body composition and reduced bone mass in growth hormone deficient hypopituitary adults // Clinical Endocrinology. — 1995. — Vol. 42. — P. 179-189.

Beshyah S.A., Freemantle C., Thomas E. Abnormal body composition and reduced bone mass in growth hormone deficient hypopituitary adults // Clinical Endocrinology. — 1995. — Vol. 42. — P. 179-189.

De Boer H., Blok G.J., Voerman H.J. Serum lipid levels in growth hormone deficient men // Metabolism. — 1994. — Vol. 43. — P. 199-203.

De Boer H., Blok G.J., Van der Veen E.A. Clinical aspects of growth hormone deficiency in adults // Endocrine Reviews. — 1995. — Vol. 16. — P. 63-86.

Bolow B., Hagmar L., Mikoczy Z. Increased cerebrovascular mortality in patients with hypopituitarism // Journal of Clinical Endocrinology and Metabolism. — 1997. — Vol. 46. — P. 75-81.

Casanueva F.F., Leal Cerro A., Koltowska-Hoggstrom M. Traumatic brain injury as a relevant cause of growth hormone deficiency in adults. A KIMS based study // Archives of Physical Medicine and Rehabilitation. — 2005. — Vol. 3. — P. 463-468.

Chrisoulidou A., Beshay S.A., Rutherford O. Effect of 7 years of growth hormone replacement therapy in hypopituitary adults // Journal of Clinical Endocrinology and Metabolism. — 2000. — Vol. 85. — P. 3762-3769.

Christ E.R., Cummings M.H., Albany E. Effects of growth hormone (GH) replacement therapy on very low density lipoprotein apolipoprotein B100 kinetics in patients with adult GH deficiency: a stable isotope study // Journal of Clinical Endocrinology and Metabolism. — 1999. — Vol. 84. — P. 307-316.

Fideleff H.L., Boquete H.R., Stalldecker G. Comparative results of a 4-year study on cardiovascular parameters, lipid metabolism, body composition and bone mass between untreated and treated adult growth hormone deficient patients // Growth Hormone and IGF Research. — 2008. — Vol. 18. — P. 318-324.

Hoybye C., Jonsson P., Monson J.P. Impact of the primary aetiology upon the clinical outcome of adults with childhood-onset growth hormone deficiency // European Journal of Endocrinology. — 2007. — Vol. 157. — P. 589-596.

Johansson J.-O., Landin K., Tengborn L. High fibrinogen and plasminogen activator inhibitor activity in growth hormone deficient adults // Arteriosclerosis and Thrombosis. — 1994. — Vol. 14. — P. 434-437.

Keletimur F., Jonsson P., Molvalilar S. Sheehan’s syndrome: baseline characteristics and effects of 2 years of growth hormone replacement therapy in 91 patients in KIMS — Pfizer International Metabolic Database // European Journal of Endocrinology. — 2005. — Vol. 152. — P. 581-587.

Leonsson M., Hulthe J., Oscarsson J. Intima-media thickness in cardiovascularly asymptomatic hypopituitary adults with growth hormone deficiency: relation to body mass index, gender, and other cardiovascular risk factors // Clinical Endocrino-logy. — 2002. — Vol. 57. — P. 751-759.

Leonsson M., Hulthe J., Johannsson G. Increased interleukin-6 levels in pituitary-deficient patients are independently related to their carotic intima-media thickness // Clinical Endocrinology. — 2003. — 59. — 242-250.

Lonn L., Johansson G., Sjostrom L. Body composition and tissue distributions in growth hormone deficient adults before and after growth hormone treatment // Obesity Research. — 1996. — Vol. 4. — P. 45-54.

Lonn L., Kvist H., Grangеrd U. CT-determined body composition changes with recombinant human growth hormone treatment to adults with growth hormone deficiency // Basic Life Sciences. — 1993. — Vol. 60. — P. 229-231.

Monson J.P., Jonsson P., Koltowska-Hoggstrom M. Growth hormone replacement decreases serum total and LDL-cholesterol in hypopituitary patients on maintenance HMG CoA reductase inhibitor (statin) therapy // Clinical Endocrinology. — 2007. — Vol. 67. — P. 623-628.

Monson J.P., Abs R., Bengtsson B.-Е., Bennmarker H. Growth hormone deficiency and replacement in elderly hypopituitary adults // Clinical Endocrinology. — 2000. — Vol. 53. — P. 281-289.

Maiter D., Abs R., Johannsson G. Baseline characteristics and response to growth hormone (GH) replacement of hypopituitary patients previously irradiated for pituitary adenoma or craniopharyngioma: data from KIMS (Pfizer International Metabolic Database) // European Journal of Endocrinology. — 2006. — Vol. 155. — P. 253-260.

Press M. Growth hormone and metabolism // Diabetes Metabolism Reviews. — 1988. — Vol. 4. — P. 391-414.

Rudling M., Parini P., Angelin B. Growth hormone and bile acid synthesis. Key role for the activity of hepatic microsomal cholesterol 7-hydroxylase in the rat // Journal of Clinical Investigation. — 1997. — Vol. 99. — P. 2239-2245.

Tomlinson J.W., Holden N., Hills R.K. Association between premature mortality and hypopituitarism. West Midland Prospective Hypopituitarism Group // Lancet. — 2001. — Vol. 357. — P. 425-431.

Sanmarti A., Lucas A., Hawkins F. Observational study in adult hypopituitary patients with untreated growth hormone deficiency (ODA study). Socio-economic impact and health status. Collaborative ODA (Observational GH Deficiency in Adults) Group // European Journal of Endocrinology. — 1999. — Vol. 141. — P. 481-489.

Snel Y.E., Brummer R.J., Doerga M.E. Adipose tissue assessed by magnetic resonance imaging in growth hormone-deficient adults: the effect of growth hormone replacement and a comparison with control subjects // American Journal of Clinical Nutrition. — 1995. — Vol. 61. — P. 1290-1294.

Stewart P.M., Sheppard M.C. Mortality and hypopituitarism // Growth Hormone and IGF Research. — 1999. — Vol. 9. — P. 15-19.

Svensson J., Bengtsson B.-Е., Rosen T. Malignant disease and cardiovascular morbidity in hypopituitary adults with or without growth hormone replacement therapy // Journal of Clinical Endocrinology and Metabolism. — 2004. — Vol. 89. — P. 3306-3312.

Vahl N., Klausen I., Christiansen J.S. Growth hormone status is an independent determinant of serum levels of cholesterol and triglycerides in healthy subjects // Clinical Endocrinology. — 1999. — Vol. 51. — P. 309-316.

Verhelst J., Abs R. Cardiovascular risk factors in hypopituitary GH-deficient adults // Eur. J. Endocrinol. — 2009. — Vol. 161.

Verhelst J., Kendall-Taylor P., Erfurth E.M. Baseline characteristics and response to 2 years of growth hormone (GH) replacement of hypopituitary patients with GH deficiency due to adult-onset craniopharyngioma in comparison with patients with non-functioning pituitary adenoma: data from KIMS // Journal of Clinical Endocrinology and Metabolism. — 2005. — Vol. 90. — P. 4636-643.

Webb S.M., Mo D., Lamberts S.W., Melmed S. Metabolic, cardiovascular, and cerebrovascular outcomes in growth hormone-deficient subjects with previous cushing’s disease or non-functioning pituitary adenoma // J. Clin. Endocrinol. Metab. — 2010. — Vol. 95(2). — P. 630-638.




DOI: https://doi.org/10.22141/2224-0721.5.53.2013.84509

Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

 

© "Publishing House "Zaslavsky", 1997-2018

 

   Seo анализ сайта